LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

Search

STERIS PLC

Open

SectorHealthcare

241.89 -0.53

Overview

Share price change

24h

Current

Min

241.87

Max

244.67

Key metrics

By Trading Economics

Income

-27M

146M

Sales

110M

1.5B

P/E

Sector Avg

39.363

51.198

EPS

2.74

Dividend yield

0.94

Profit margin

9.892

Employees

17,787

EBITDA

-158M

216M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+9.8% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

0.94%

2.40%

Next Earnings

5 Aug 2025

Next Dividend date

26 Jun 2025

Next Ex Dividend date

10 Jun 2025

Market Stats

By TradingEconomics

Market Cap

912M

24B

Previous open

242.42

Previous close

241.89

News Sentiment

By Acuity

27%

73%

71 / 380 Healthcare

Technical Score

By Trading Central

Confidence

Bearish Evidence

STERIS PLC Chart

Past performance is not a reliable indicator of future results.

Related News

14 May 2025, 20:30 UTC

Earnings

Steris Sees FY Adj EPS $9.90-Adj EPS $10.15 >STE

14 May 2025, 20:30 UTC

Earnings

Steris 4Q Rev $1.5B >STE

14 May 2025, 20:30 UTC

Earnings

Steris 4Q Adj EPS $2.74 >STE

5 Feb 2025, 21:35 UTC

Earnings

Steris: Outlook Does Not Reflect Any Potential Impact From New Tariffs >STE

5 Feb 2025, 21:34 UTC

Earnings

Steris: FY25 Guidance Change Is Primarily Due to Currency >STE

5 Feb 2025, 21:34 UTC

Earnings

Steris Cuts FY25 Revenue View to Increase of About 6% From Prior View for 6.5%-7%>STE

5 Feb 2025, 21:33 UTC

Earnings

Steris 3Q EPS $1.75 >STE

5 Feb 2025, 21:30 UTC

Earnings

Steris Sees FY Adj EPS $9.05-Adj EPS $9.15 >STE

5 Feb 2025, 21:30 UTC

Earnings

Steris 3Q Rev $1.4B >STE

5 Feb 2025, 21:30 UTC

Earnings

Steris 3Q Adj EPS $2.32 >STE

6 Nov 2024, 21:41 UTC

Earnings

Steris Backs FY25 Revenue Up 6.5%-7.5% >STE

6 Nov 2024, 21:40 UTC

Earnings

Steris 2Q EPS $1.51 >STE

6 Nov 2024, 21:30 UTC

Earnings

Steris Sees FY Adj EPS $9.05-Adj EPS $9.25 >STE

6 Nov 2024, 21:30 UTC

Earnings

Steris 2Q Adj EPS $2.14 >STE

6 Nov 2024, 21:30 UTC

Earnings

Steris 2Q Rev $1.3B >STE

6 Aug 2024, 20:36 UTC

Earnings

Steris 1Q Adj EPS $2.03 >STE

6 Aug 2024, 20:30 UTC

Earnings

Steris 1Q Net $139.9M >STE

6 Aug 2024, 20:30 UTC

Earnings

Steris 1Q EPS $1.41 >STE

6 Aug 2024, 20:30 UTC

Earnings

Steris Sees FY Adj EPS $9.05-Adj EPS $9.25 >STE

Peer Comparison

Price change

STERIS PLC Forecast

Price Target

By TipRanks

9.8% upside

12 Months Forecast

Average 265.83 USD  9.8%

High 280 USD

Low 250 USD

Based on 7 Wall Street analysts offering 12 month price targets forSTERIS PLC - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

7 ratings

4

Buy

3

Hold

0

Sell

Technical Score

By Trading Central

225 / 226.35Support & Resistance

Short Term

Bearish Evidence

Intermediate Term

Strong Bullish Evidence

Long Term

Strong Bullish Evidence

Sentiment

By Acuity

71 / 380 Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About STERIS PLC

STERIS plc provides infection prevention products and services worldwide. It operates through three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument, devices, and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The AST segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of contract sterilization and laboratory facilities, as well as integrated sterilization equipment and control systems to medical device manufacturers and research institutions. The Life Sciences segment designs, manufactures, and sells consumable products, such as pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. It serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is headquartered in Mentor, Ohio.